These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 2253412)
1. Production of immunoreactive inhibin by a virilizing ovarian tumour (Sertoli-Leydig tumour). Ohashi M; Hasegawa Y; Haji M; Igarashi M; Nawata H Clin Endocrinol (Oxf); 1990 Nov; 33(5):613-8. PubMed ID: 2253412 [TBL] [Abstract][Full Text] [Related]
2. Ageing, testicular tumours and the pituitary-testis axis in dogs. Peters MA; de Jong FH; Teerds KJ; de Rooij DG; Dieleman SJ; van Sluijs FJ J Endocrinol; 2000 Jul; 166(1):153-61. PubMed ID: 10856894 [TBL] [Abstract][Full Text] [Related]
3. Inhibin gene expression in a large cell calcifying Sertoli cell tumour and serum inhibin and activin levels. Toppari J; Kaipia A; Kaleva M; Laato M; de Kretser DM; Krummen LA; Mather JP; Salmi TT APMIS; 1998 Jan; 106(1):101-12; discussion 112-3. PubMed ID: 9524568 [TBL] [Abstract][Full Text] [Related]
4. An immunohistological study of steroid localization in Sertoli-Leydig tumors of the ovary and testis. Kurman RJ; Andrade D; Goebelsmann U; Taylor CR Cancer; 1978 Oct; 42(4):1772-83. PubMed ID: 361211 [TBL] [Abstract][Full Text] [Related]
5. Norethindrone inhibition of testosterone secretion by an ovarian Sertoli-Leydig cell tumor. Brumsted JR; Chapitis J; Riddick D; Gibson M J Clin Endocrinol Metab; 1987 Jul; 65(1):194-7. PubMed ID: 3584396 [TBL] [Abstract][Full Text] [Related]
6. Androgen suppressive effect of GnRH agonist in ovarian hyperthecosis and virilizing tumours. Pascale MM; Pugeat M; Roberts M; Rousset H; Déchaud H; Dutrieux-Berger N; Tourniaire J Clin Endocrinol (Oxf); 1994 Nov; 41(5):571-6. PubMed ID: 7828344 [TBL] [Abstract][Full Text] [Related]
7. Steroid biosynthesis in the Sertoli-Leydig cell tumor: effects of insulin and luteinizing hormone. Nagamani M; Stuart CA; Van Dinh T Am J Obstet Gynecol; 1989 Dec; 161(6 Pt 1):1738-43. PubMed ID: 2532472 [TBL] [Abstract][Full Text] [Related]
8. Postmenopausal androgen secreting ovarian tumour: pathophysiological implications; a case report. Pérez A; Calaf J; Webb SM; Prat J; de Leiva A Eur J Obstet Gynecol Reprod Biol; 1990 Apr; 35(1):97-105. PubMed ID: 2107106 [TBL] [Abstract][Full Text] [Related]
9. Elevated serum immunoreactive inhibin levels in peripubertal boys with chronic renal failure. Cooperative Study Group on Pubertal Development in Chronic Renal Failure (CSPCRF). Mitchell R; Schaefer F; Morris ID; Schärer K; Sun JG; Robertson WR Clin Endocrinol (Oxf); 1993 Jul; 39(1):27-33. PubMed ID: 8348705 [TBL] [Abstract][Full Text] [Related]
10. Elevated levels of inhibin-A and immunoreactive inhibin in aged male Wistar rats with testicular Leydig cell tumor. Herath CB; Watanabe G; Wanzhu J; Noguchi J; Akiyama K; Kuramoto K; Groome NP; Taya K J Androl; 2001; 22(5):838-46. PubMed ID: 11545298 [TBL] [Abstract][Full Text] [Related]
11. A paradoxical inhibition of androgenic hyperproduction by a Sertoli-Leydig cell tumour ovary. Amato G; Izzo G; Izzo A Hum Reprod; 1995 Nov; 10(11):2967-9. PubMed ID: 8747056 [TBL] [Abstract][Full Text] [Related]
12. Inhibin A is a sensitive and specific marker for testicular sex cord-stromal tumors. Iczkowski KA; Bostwick DG; Roche PC; Cheville JC Mod Pathol; 1998 Aug; 11(8):774-9. PubMed ID: 9720507 [TBL] [Abstract][Full Text] [Related]
13. Inhibin, gonadotrophins and sex steroids in dogs with Sertoli cell tumours. Grootenhuis AJ; van Sluijs FJ; Klaij IA; Steenbergen J; Timmerman MA; Bevers MM; Dieleman SJ; de Jong FH J Endocrinol; 1990 Nov; 127(2):235-42. PubMed ID: 2123496 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of inhibin-alpha, -betaB, and -betaA chains and 3beta-hydroxysteroid dehydrogenase in canine testicular tumors and normal testes. Taniyama H; Hirayama K; Nakada K; Numagami K; Yaosaka N; Kagawa Y; Izumisawa Y; Nakade T; Tanaka Y; Watanabe G; Taya K Vet Pathol; 2001 Nov; 38(6):661-6. PubMed ID: 11732800 [TBL] [Abstract][Full Text] [Related]
16. Characterization of inhibin immunoreactivity in post-menopausal women with ovarian tumours. Burger HG; Robertson DM; Cahir N; Mamers P; Healy DL; Jobling T; Groome N Clin Endocrinol (Oxf); 1996 Apr; 44(4):413-8. PubMed ID: 8706307 [TBL] [Abstract][Full Text] [Related]
17. Sertoli-Leydig cell tumor of the ovary producing alpha-fetoprotein. Chumas JC; Rosenwaks Z; Mann WJ; Finkel G; Pastore J Int J Gynecol Pathol; 1984; 3(2):213-9. PubMed ID: 6208158 [TBL] [Abstract][Full Text] [Related]
18. Production of inhibin A and inhibin B in human ovarian sex cord stromal tumors. Yamashita K; Yamoto M; Shikone T; Minami S; Imai M; Nishimori K; Nakano R Am J Obstet Gynecol; 1997 Dec; 177(6):1450-7. PubMed ID: 9423750 [TBL] [Abstract][Full Text] [Related]
19. Peripheral vein, ovarian vein and ovarian tissue levels of inhibin in a postmenopausal patient with a granulosa cell tumour. Sluijmer AV; Heineman MJ; Evers JL; de Jong FH Acta Endocrinol (Copenh); 1993 Oct; 129(4):311-4. PubMed ID: 8237248 [TBL] [Abstract][Full Text] [Related]
20. Steroid biosynthesis in the Sertoli-Leydig cell tumor tissue of the human ovary; enzymhistochemical and immunohistochemical studies. Goslar HG; Haider SG; Freundl G; Pickartz H; Passia D Acta Histochem Suppl; 1984; 29():175-7. PubMed ID: 6425925 [No Abstract] [Full Text] [Related] [Next] [New Search]